Current trends in colchicine treatment in familial Mediterranean fever

Raffaele Manna, Eldad Ben-Chetrit, Armen Yuri Gasparyan, Avi Livneh, Huri Ozdogan

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Since the publication of the first reports on the efficiency of colchicine in familial Mediterranean fever (FMF), very few randomised studies have investigated issues related to its long-term use. Thus, different approaches taken by physicians involved in FMF care, are exclusively empiric, emulative, and based on case-reports or case-series. Problems such as colchicine intolerance and colchicine resistance have not been solved yet. This paper aims to evaluate trends in colchicine therapy among physicians taking care of FMF patients around the world.
Original languageEnglish
Pages (from-to)41-46
Number of pages6
JournalCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Volume31
Publication statusPublished - 2013

Keywords

  • Asia
  • Colchicine
  • Europe
  • Familial Mediterranean Fever
  • Female
  • Health Care Surveys
  • Humans
  • Immunosuppressive Agents
  • Male
  • Physician's Practice Patterns
  • Predictive Value of Tests
  • Prevalence
  • Questionnaires
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Current trends in colchicine treatment in familial Mediterranean fever'. Together they form a unique fingerprint.

Cite this